You are here

Vorapaxar

Europe gives green light to AbbVie hepatitis C medicine, others

Yahoo/Reuters

Fri, 11/21/14 - 08:11 am

Boehringer Ingelheim

Merck Gets Good News On New Heart Attack Therapy

Motley Fool

Thu, 01/23/14 - 05:58 pm

FDA advisory panel backs Merck's blood clot-preventing drug

Reuters

Wed, 01/15/14 - 05:50 pm

advisory panels

Merck's anti-blood clot drug should be approved -U.S. FDA staff

Yahoo/Reuters

Mon, 01/13/14 - 09:01 am

Possible New Lease On Life For Two Cardiology Drugs From Merck And J&J

Forbes

Mon, 12/16/13 - 02:16 pm

Merck announces FDA acceptance of new drug application for vorapaxar

Yahoo/Fly on the Wall

Wed, 07/24/13 - 09:35 am

Vorapaxar For Patients With Previous MI And Merck's Bottom Line

Seeking Alpha

Sat, 10/6/12 - 11:46 am

myocardial infarction

Merck will seek approval of 2 heart drugs in 2013

Yahoo/AP

Mon, 08/27/12 - 05:26 pm

Merck Provides Update on Cardiovascular Development Programs

Yahoo/BusinessWire

Sun, 08/26/12 - 11:58 am

Mixed Data on Merck's Vorapaxar

Yahoo/Zacks.com

Wed, 03/28/12 - 04:14 pm

Merck Blood Thinner Stops Heart Attacks With Risk of Bleeding

Bloomberg

Sat, 03/24/12 - 11:47 am

Merck clot drug meets study goal but bleeding a risk

Reuters

Tue, 02/7/12 - 09:59 am

Merck's Vorapaxar Disappoints

Yahoo/Zacks

Sat, 11/19/11 - 12:13 pm

acute coronary syndrome

TRACER: Novel Antiplatelet Vorapaxar Runs Into Trouble in ACS

Forbes

Sun, 11/13/11 - 12:11 pm

acute coronary syndrome

Defending Merck’s CEO

Forbes

Fri, 01/21/11 - 07:54 am

Kenneth Frazier

Don't Have a Stroke Over Merck's Heart Drug

Motley Fool

Sat, 01/15/11 - 12:34 pm

Merck Pipeline Setback: Big Pharma Losers

TheStreet.com

Thu, 01/13/11 - 12:20 pm

Merck tumbles on drug study woes

Marketwatch

Thu, 01/13/11 - 12:04 pm

Pipeline Checkup: Merck Has Potential

Motley Fool

Tue, 08/31/10 - 07:17 am

How To Tell Merck's Two Blood Thinners Apart

Forbes

Fri, 05/14/10 - 08:23 am

Pages